Robert J. Spiegel, Director at Edge Therapeutics, Inc. (EDGE), bought 28,128 shares at $11.00 ($45K) on 2015-10-06, disclosed to the SEC on 2015-10-08.
Open-market purchase of $45k EDGE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 23,579 | $0 | 0.0% |
| 2 | $7.91 | 1,549 | $12K | 27.1% |
| 3 | $11.00 | 3,000 | $33K | 72.9% |
| Total | $1.61 avg | 28,128 | $45K | 100% |
| Filing → |
| PTCT | SELL | 2014-03-14 | $38K | — | Filing → |